Open Access6 versus 12 months of adjuvant trastuzumab in HER2+ early breast cancer
Author(s) -
Bi-Cheng Wang,
Bo-Ya Xiao,
JinHu Fan,
Guo-He Lin,
Chang Wang,
Quentin Liu,
Yuliang Zhao
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000024995
Subject(s) - medicine , trastuzumab , hazard ratio , breast cancer , adjuvant , oncology , clinical endpoint , confidence interval , adjuvant therapy , meta analysis , cochrane library , randomized controlled trial , cancer , surgery